China Health Industries (CHHE) Stock Price, News & Analysis

Company Overview

China Health Industries Holdings Inc. (OTCMKTS: CHHE) is a China-based healthcare company engaged in the research, development, production and distribution of pharmaceutical products and health supplements. The company’s activities encompass both traditional Chinese medicine and modern pharmaceutical formulations, focusing on therapeutic categories such as antibiotics, analgesics, antipyretics, Chinese patent medicines and dietary supplements. Through its integrated operations, China Health Industries seeks to deliver a diverse portfolio of healthcare solutions that address a range of patient needs across multiple therapeutic areas.

The company’s product offerings include over-the-counter remedies and prescription medicines, along with health food products designed to support general wellness. These items are manufactured in compliance with relevant regulatory standards and are distributed through a network of hospitals, retail pharmacies and e-commerce platforms. China Health Industries invests in quality control and manufacturing technologies to maintain consistent product integrity and to meet the evolving requirements of domestic and international markets.

China Health Industries serves customers throughout China and exports certain product lines to overseas markets. Its sales strategy leverages partnerships with local distributors, as well as direct sales via online channels. While specific leadership details and historical milestones are not widely reported, the company’s operational focus remains on expanding its product pipeline, strengthening distribution capabilities and pursuing opportunities to introduce new formulations that integrate traditional and modern medicinal approaches.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 6/15/2026
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CHHE
• CIK: 1309057
• Web: www.chinahealthindustries.com
• Phone: 8645188100688
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $110 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 64,950,000
• Free Float: 44,618,000
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A